Ribophorin II Overexpression Is Associated with Poor Response to Induction Chemotherapy with Docetaxel, Cisplatin, and Fluorouracil in P16-Negative Locally Advanced Head and Neck Squamous Cell Carcinoma
This study aims to evaluate the relationship between human ribophorin II (<i>RPN2</i>) and the effect of treatment using induction therapy with docetaxel, cisplatin, and fluorouracil (TPF) for <i>p</i>-16 negative locally advanced head and neck squamous cell carcinoma (HNSCC)...
Main Authors: | Wei-Shan Chen, Sheng-Dean Luo, Tai-Jan Chiu, Yu-Ming Wang, Wei-Chih Chen, Chih-Yen Chien, Fu-Min Fang, Tai-Lin Huang, Shau-Hsuan Li |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-09-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/10/18/4118 |
Similar Items
-
Capsaicin Potentiates Anticancer Drug Efficacy Through Autophagy-Mediated Ribophorin II Downregulation and Necroptosis in Oral Squamous Cell Carcinoma Cells
by: Yi-Ching Huang, et al.
Published: (2021-08-01) -
RPN2 Gene Confers Osteosarcoma Cell Malignant Phenotypes and Determines Clinical Prognosis
by: Tomohiro Fujiwara, et al.
Published: (2014-01-01) -
Downregulation of ribophorin II suppresses tumor growth, migration, and invasion of nasopharyngeal carcinoma
by: Hong F, et al.
Published: (2018-06-01) -
Induction chemotherapy with dose-modified docetaxel, cisplatin, and 5-fluorouracil in Asian patients with borderline resectable or unresectable head and neck cancer
by: Hung-Ming Wang, et al.
Published: (2017-03-01) -
Efficacy and safety of cisplatin and weekly docetaxel in patients with recurrent or metastatic squamous cell carcinoma of the head and neck
by: Moon Jin Kim, et al.
Published: (2019-09-01)